Background: Positive associations have been observed between cardiovascular disease (CVD) and type 2 diabetes mellitus (DM), but their causal relationship has not been clarified. Nevertheless, guidelines from relevant medical societies recommend using cholesterol lowering medication (statin) for both types of patients. Medicines with several different action mechanisms have been developed, and the effectiveness of different lifestyle modifications has been studied extensively for the prevention of DM, which was successful in improving clinical marker status in relatively short-term treatments, but none have been shown to be effective in improving long-term outcomes (mortality from CVD and all causes). Summary: Statin-induced suppression of prenyl intermediates in the cholesterol biosynthetic pathway has been linked to stimulated atherosclerosis and heart failure. On the other hand, certain types of vegetable oil and hydrogenated oil shortened the survival of stroke-prone spontaneously hypertensive rats by decreasing platelet number, increasing hemorrhagic tendency and damaging kidney functions, which could not be accounted for by their fatty acid and phytosterol compositions. These vegetable oils and medicines such as statin and warfarin share, in part, a common mechanism to inhibit vitamin K2-dependent processes, which was interpreted to lead to increased onset of CVD, DM, chronic kidney disease, bone fracture and even mental disorder. Impaired vitamin K2-dependent processes by some types of vegetable oils and medicines, but not plasma high low density lipoprotein cholesterol, were proposed as the cause of CVD, DM and other lifestyle-related diseases. High n-6/n-3 fatty acid ratio of ingested foods, but not animal fats, was emphasized to be another risk factor for many of the diseases described above. Key Messages: To date, no randomized controlled trials (RCTs) have been performed to prove the above interpretation. However, the opposite types of RCT trials have been performed by increasing the intake of high-linoleic vegetable oils and reducing that of animal fats, which resulted in increased CVD and all-cause mortality. The amounts of these vegetable oils to exhibit adverse effects in animal studies are not huge (<6 energy %), which should not be overlooked nor disregarded.

Keywords:
Statin, Warfarin, Canola oil, Hydrogenated oil, Trans-fat, Cardiovascular disease, Diabetes mellitus, Vitamin K2, Osteocalcin, Testosterone
1.
Strandberg TE, Salomaa V: Factors related to the development of diabetes during a 20-year follow-up. A prospective study in a homogeneous group of middle-aged men. Nutr Metab Cardiovasc Dis 2000;10:239-246.
2.
De Lorgeril M: Cholestérol Mensonges et Propagande, Thierry Souccar Editions, 2008.
3.
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, Uchino H: Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol 2015;8:189-199.
4.
Sato T, Oouchi M, Nagakubo H, Chiba T, Ogawa S, Sato C, Sugimura K, Fukuda M: Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. Tohoku J Exp Med 1998;185:25-29.
5.
Larsen S, Stride N, Hey-Mogensen M, et al: Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance. J Am Coll Cardiol 2013;61:44-53.
6.
Shirakawa H, Katsurai T, Kimai M: Conversion of menaquinone-4 in animal organs and its function. Oleoscience 2014;14:547-561.
7.
Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G: Endocrine regulation of male fertility by the skeleton. Cell 2011;144:796-809.
8.
Oury F, Khrimian L, Denny CA, Gardin A, Chamouni A, Goeden N, Huang YY, Lee H, Srinivas P, Gao XB, Suyama S, Langer T, Mann JJ, Horvath TL, Bonnin A, Karsenty G: Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013;155:228-241.
9.
Ichiyama M, Ohga S, Ochiai M, Fukushima K, Ishimura M, Torio M, Urata M, Hotta T, Kang D, Hara T: Fetal hydrocephalus and neonatal stroke as the first presentation of protein C deficiency. Brain Dev 2016;38:253-256.
10.
Leconte I, Auzan C, Debant A, Rossi B, Clauser E: N-linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling. J Biol Chem 1992;267:17415-17423.
11.
Forbes K, Shah VK, Siddals K, Gibson JM, Aplin JD, Westwood M: Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation. Mol Hum Reprod 2015;21:105-114.
12.
Binnington B, Nguyen L, Kamani M, Hossain D, Marks DL, Budani M, Lingwood CA: Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling. Glycobiology 2016;26:166-180.
13.
Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS: Statin treatment and new-onset diabetes: a review of proposed mechanisms. Metabolism 2014;63:735-745.
14.
Carson DD, Lennarz WJ: Inhibition of polyisoprenoid and glycoprotein biosynthesis causes abnormal embryonic development. Proc Natl Acad Sci U S A 1979;76:5709-5713.
15.
Nakazato R, Gransar H, Berman DS, Cheng VY, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cury RC, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines TC, Dunning A, Feuchtner G, Kim YJ, Leipsic J, Min JK: Statins use and coronary artery plaque composition: results from the international multicenter CONFIRM registry. Atherosclerosis 2012;225:148-153.
16.
Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A, Naso A, Miozzo D, Giannini S, Avolio M, Foschi A, Rizzo MA, Gallieni M; Vertebral Fractures and Vascular Calcifications Study Group: Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol 2015;13:248-258.
17.
Schurgers LJ, Aebert H, Vermeer C, Bültmann B, Janzen J: Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 2004;104:3231-3232.
18.
Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC: Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutr 2004;134:3100-3105.
19.
Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229-241.
20.
Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145-154.
21.
Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E; Look AHEAD Adipose Research Group: Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 2010;59:627-633.
22.
Goran MI, Ulijaszek SJ, Ventura EE: High fructose corn syrup and diabetes prevalence: a global perspective. Glob Public Health 2013;8:55-64.
23.
Gross LS, Li L, Ford ES, Liu S: Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004;79:774-779.
24.
Bunn HF, Higgins PJ: Reaction of monosaccharides with proteins: possible evolutionary significance. Science 1981;213:222-224.
25.
Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-1334.
26.
Kuzuya T, Ito C, Sasaki A, Seino Y, Tajima N, Doi K, Nunoi K, Matsuda A, Uehata T: Prevalence and incidence of diabetes in Japanese people compiled from the literature - a report of the epidemiology data committee, the Japan diabetes society. J Japan Diab Soc 1992;35:173-194.
27.
Kiyohara Y: Naze Hisayamachou de Tounyoubyou ga huetanoka? (Why diabetics increased in Hisayama town?). Eiyou to Ryouri 2013;110-115.
28.
Sekikawa A, Eguchi H, Tominaga M, Igarashi K, Abe T, Manaka H, Sasaki H, Fukuyama H, Kato T, Kiyohara Y, Fujishima M: Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study. J Diabetes Complications 2000;14:78-83.
29.
Tsuji H, Shiojima I: [Effect of the national lifestyle modification project conducted in Japan on the parameters of metabolic syndrome]. Nihon Koshu Eisei Zasshi 2015;62:402-411.
30.
Tomonou M, Shirota T, Uchida K, Kiyohara Y: [Changes of nutritional intakes and food group intakes over a 40-year period in Hisayama]. Nakamura Gakuen University Kiyou 2007;39:255-262.
31.
Shirota T, Oishi A, Shinohara A, Uchida K, Kiyohara Y, Fujishima M: [Changes in nutritional status and nutritional intake among elderly residents of a community over a 10-year period: the Hisayama study]. Nihon Ronen Igakkai Zasshi 2002;39:69-74.
32.
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
33.
Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA, Booth GL; ACCORD Study Group: Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet 2014;384:1936-1941.
34.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139.
35.
Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV; VADT Investigators: Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;372:2197-2206.
36.
Dam V, Dalmeijer GW, Vermeer C, Drummen NE, Knapen MH, van der Schouw YT, Beulens JW: Association between vitamin K and the metabolic syndrome: a 10-year follow-up study in adults. J Clin Endocrinol Metab 2015;100:2472-2479.
37.
Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL: Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 2009;90:1230-1235.
38.
Yoshida M, Jacques PF, Meigs JB, Saltzman E, Shea MK, Gundberg C, Dawson-Hughes B, Dallal G, Booth SL: Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008;31:2092-2096.
39.
Okuyama H, Ichikawa Y, Sun YJ, Hamazaki T, Lands WE: Prevention of Coronary Heart Disease - From the Cholesterol Hypothesis to ω6 to ω3 Balance. Basel, Karger, 2007.
40.
Huang MZ, Watanabe S, Kobayashi T, Nagatsu A, Sakakibara J, Okuyama H: Unusual effects of some vegetable oils on the survival time of stroke-prone spontaneously hypertensive rats. Lipids 1997;32:745-751.
41.
Ratnayake WM, Plouffe L, Hollywood R, L'Abbé MR, Hidiroglou N, Sarwar G, Mueller R: Influence of sources of dietary oils on the life span of stroke-prone spontaneously hypertensive rats. Lipids 2000;35:409-420.
42.
Ratnayake WM, L'Abbé MR, Mueller R, Hayward S, Plouffe L, Hollywood R, Trick K: Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr 2000;130:1166-1178.
43.
Tatematsu K, Fuma SY, Nagase T, Ichikawa Y, Fujii Y, Okuyama H: Factors other than phytosterols in some vegetable oils affect the survival of SHRSP rats. Food Chem Toxicol 2004;42:1443-1451.
44.
Ohara N, Naito Y, Nagata T, Tatematsu K, Fuma SY, Tachibana S, Okuyama H: Exploration for unknown substances in rapeseed oil that shorten survival time of stroke-prone spontaneously hypertensive rats. Effects of super critical gas extraction fractions. Food Chem Toxicol 2006;44:952-963.
45.
Ohara N, Kasama K, Naito Y, Nagata T, Saito Y, Kuwagata M, Okuyama H: Different effects of 26-week dietary intake of rapeseed oil and soybean oil on plasma lipid levels, glucose-6-phosphate dehydrogenase activity and cyclooxygenase-2 expression in spontaneously hypertensive rats. Food Chem Toxicol 2008;46:2573-2579.
46.
Ogawa H, Yamamoto K, Kamisako T, Meguro T: Phytosterol additives increase blood pressure and promote stroke onset in salt-loaded stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003;30:919-924.
47.
Miyazaki M, Huang MZ, Takemura N, Watanabe S, Okuyama H: Free fatty acid fractions from some vegetable oils exhibit reduced survival time-shortening activity in stroke-prone spontaneously hypertensive rats. Lipids 1998;33:655-661.
48.
Okuyama H, Yamada K, Miyazawa D, Yasui Y, Ohara N: Dietary lipids impacts on healthy ageing. Lipids 2007;42:821-825.
49.
Hashimoto Y, Mori M, Kobayashi S, Hanya A, Watanabe S, Ohara N, Noguchi T, Kawai T, Okuyama H: Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in mice. Toxicol Rep 2014;1:955-962.
50.
Booth SL, Lichtenstein AH, O'Brien-Morse M, McKeown NM, Wood RJ, Saltzman E, Gundberg CM: Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 2001;74:783-790.
51.
da Costa CA, Carlos AS, de Sousa Dos Santos A, de Moura EG, Nascimento-Saba CC: High-fat diets containing soybean or canola oil affect differently pancreas function of young male rats. Horm Metab Res 2013;45:652-654.
52.
Papazzo A, Conlan XA, Lexis L, Lewandowski PA: Differential effects of dietary canola and soybean oil intake on oxidative stress in stroke-prone spontaneously hypertensive rats. Lipids Health Dis 2011;10:98.
53.
Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N, Ikeda Y, Nobukata H, Ishikawa T, Shibutani Y: Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 1997;46:1458-1464.
54.
Okuyama H, Lands WE, Gunstone FD, Barve JA: Selective transfers of trans-ethylenic acids by acyl coenzyme A. Phospholipid acyltransferases. Biochemistry 1972;11:4392-4398.
55.
de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, Uleryk E, Budylowski P, Schünemann H, Beyene J, Anand SS: Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015;351:h3978.
56.
Gebauer SK, Destaillats F, Dionisi F, Krauss RM, Baer DJ: Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr 2015;102:1339-1346.
57.
Troy LM, Jacques PF, Hannan MT, Kiel DP, Lichtenstein AH, Kennedy ET, Booth SL: Dihydrophylloquinone intake is associated with low bone mineral density in men and women. Am J Clin Nutr 2007;86:504-508.
58.
Hamazaki K, Suzuki N, Kitamura K, Hattori A, Nagasawa T, Itomura M, Hamazaki T: Is vaccenic acid (18:1t n-7) associated with an increased incidence of hip fracture? An explanation for the calcium paradox. Prostag Leukotr Ess 2016;109:8-12.
59.
Hamazaki T, Okuyama H, Ogushi Y, Hama R: Towards a paradigm shift in cholesterol treatment. A re-examination of the cholesterol issue in Japan. Ann Nutr Metab 2015;66(suppl 4):1-116.
60.
Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators: Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-2122.
61.
Narisawa T, Takahashi M, Kotanagi H, Kusaka H, Yamazaki Y, Koyama H, Fukaura Y, Nishizawa Y, Kotsugai M, Isoda Y, et al: Inhibitory effect of dietary perilla oil rich in the n-3 polyunsaturated fatty acid alpha-linolenic acid on colon carcinogenesis in rats. Jpn J Cancer Res 1991;82:1089-1096.
62.
Onogi N, Okuno M, Komaki C, Moriwaki H, Kawamori T, Tanaka T, Mori H, Muto Y: Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats. Carcinogenesis 1996;17:1291-1296.
63.
Takeshita M, Ueda H, Shirabe K, Higuchi Y, Yoshida S: Lack of promotion of colon carcinogenesis by high-oleic safflower oil. Cancer 1997;79:1487-1493.
64.
Suzuki H, Yamazaki M, Arai S, Nagao A, Terao J: Effect of lard, palm and rapeseed oils life conservation in aged mice. Mech Ageing Dev 1991;60:267-274.
65.
Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Ezaki O: High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism 1996;45:1539-1546.
66.
de Lorgeril M, Salen P, Paillard F, Laporte F, Boucher F, de Leiris J: Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res 2002;54:503-515.
67.
Ferrières J: The French paradox: lessons for other countries. Heart 2004;90:107-111.
68.
Renaud S, Lanzmann-Petithory D: Coronary heart disease: dietary links and pathogenesis. Public Health Nutr 2001;4:459-474.
69.
Strandberg TE, Salomaa VV, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA: Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991;266:1225-1229.
70.
Okuyama H, Kobayashi T, Watanabe S: Dietary fatty acids - the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res 1996;35:409-457.
71.
Lands WE: Fish, Omega-3 and Human Health, ed 2. AOCS Publishing, 2005.
72.
Ottoboni A, Ottoboni F: The Modern Nutritional Diseases, ed 2. Fernley, Vincente Books, 2015.
73.
Serhan CN, Hong S, Gronert K, et al: Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025-1037.
74.
Katakura M, Hashimoto M, Inoue T, Al Mamun A, Tanabe Y, Iwamoto R, Arita M, Tsuchikura S, Shido O: Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. Molecules 2014;19:3247-3263.
75.
Kang JX: A transgenic mouse model for gene-nutrient interactions. J Nutrigenet Nutrigenomics 2008;1:172-177.
76.
Kang JX, Gleason ED: Omega-3 fatty acids and hippocampal neurogenesis in depression. CNS Neurol Disord Drug Targets 2013;12:460-465.
77.
Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, Guesnet P, Amri EZ, Negrel R, Ailhaud G: Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res 2003;44:271-279.
78.
Li P, Oh da Y, Bandyopadhyay G, Lagakos WS, Talukdar S, Osborn O, Johnson A, Chung H, Mayoral R, Maris M, Ofrecio JM, Taguchi S, Lu M, Olefsky JM: LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat Med 2015;21:239-247.
79.
Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, Giles GG: Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007;86:189-197.
80.
Kusunoki M, Tsutsumi K, Nakayama M, Kurokawa T, Nakamura T, Ogawa H, Fukuzawa Y, Morishita M, Koide T, Miyata T: Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus. J Med Invest 2007;54:243-247.
81.
Jacobs S, Schiller K, Jansen EH, Boeing H, Schulze MB, Kröger J: Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European prospective investigation into cancer and nutrition-potsdam study. Am J Clin Nutr 2015;102:155-164.
82.
Kameyama T, Ohhara T, Nakashima Y, Naito Y, Huang MZ, Watanabe S, Kobayashi T, Okuyama H, Yamada K, Nabeshima T: Effects of dietary vegetable oils on behavior and drug responses in mice. Biol Pharm Bull 1996;19:400-404.
83.
Nakashima Y, Yuasa S, Hukamizu Y, Okuyama H, Ohhara T, Kameyama T, Nabeshima T: Effect of a high linoleate and a high alpha-linolenate diet on general behavior and drug sensitivity in mice. J Lipid Res 1993;34:239-247.
84.
Okuyama H, Ohara N, Tatematsu K, Fuma S, Nonogaki T, Yamada K, Ichikawa Y, Miyazawa D, Yasui Y, Honma S: Testosterone-lowering activity of canola and hydrogenated soybean oil in the stroke-prone spontaneously hypertensive rat. J Toxicol Sci 2010;35:743-747.
85.
Iwamoto T, Nozawa S, Yoshiike M, Hoshino T, Baba K, Matsushita T, Tanaka SN, Naka M, Skakkebaek NE, Jørgensen N: Semen quality of 324 fertile Japanese men. Hum Reprod 2006;21:760-765.
86.
Rotkiewicz T, Bomba G, Falkowski J, Glogowski J, Kozera W, Kozłowski M: Studies on a long-term use of rapeseed products in diets for boars. Pathomorphological changes in the reproductive system, liver and thyroid gland. Reprod Nutr Dev 1997;37:675-690.
87.
Andersson AM, Jørgensen N, Main KM, Toppari J, Rajpert-De Meyts E, Leffers H, Juul A, Jensen TK, Skakkebæk NE: Adverse trends in male reproductive health: we may have reached a crucial ‘tipping point'. Int J Androl 2008;31:74-80.
88.
Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N: Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007;116:2694-2701.
89.
Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, Morales AM, Volterrani M, Yellowlees A, Howell JD, Channer KS; TIMES2 Investigators: Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011;34:828-837.
90.
Calder PC: Old study sheds new light on the fatty acids and cardiovascular health debate. BMJ 2013;346:f493.
91.
Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR: Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney diet heart study and updated meta-analysis. BMJ 2013;346:e8707.
92.
Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP, Davis JM, Ringel A, Suchindran CM, Hibbeln JR: Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota coronary experiment (1968-73). BMJ 2016;353:i1246.
93.
Ravnskov U, Diamond D, Karatay MC, Miller DW, Okuyama H: No scientific support for linking dietary saturated fat to CHD. Br J Nutr 2012;107:455-457; author reply 458-460.
94.
Bibus D, Lands B: Balancing proportions of competing omega-3 and omega-6 highly unsaturated fatty acids (HUFA) in tissue lipids. Prostaglandins Leukot Essent Fatty Acids 2015;99:19-23.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.